I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 11 studies | 24% ± 9% | |
| ciliated cell | 10 studies | 28% ± 10% | |
| oligodendrocyte precursor cell | 9 studies | 27% ± 11% | |
| neuron | 6 studies | 29% ± 14% | |
| fibroblast | 6 studies | 22% ± 5% | |
| GABAergic neuron | 6 studies | 31% ± 16% | |
| astrocyte | 6 studies | 26% ± 9% | |
| oligodendrocyte | 6 studies | 23% ± 7% | |
| glutamatergic neuron | 5 studies | 39% ± 20% | |
| interneuron | 5 studies | 28% ± 17% | |
| epithelial cell | 5 studies | 35% ± 15% | |
| basal cell | 4 studies | 29% ± 11% | |
| ionocyte | 3 studies | 30% ± 2% | |
| secretory cell | 3 studies | 19% ± 1% | |
| B cell | 3 studies | 20% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 20% ± 0% | |
| non-classical monocyte | 3 studies | 31% ± 10% | |
| retinal bipolar neuron | 3 studies | 20% ± 3% | |
| microglial cell | 3 studies | 19% ± 3% | |
| connective tissue cell | 3 studies | 28% ± 8% | |
| squamous epithelial cell | 3 studies | 29% ± 11% | |
| natural killer cell | 3 studies | 19% ± 2% | |
| enteroendocrine cell | 3 studies | 29% ± 16% |
